D-0011-2025 Class II Ongoing

Recalled by VIONA PHARMACEUTICALS INC — Cranford, NJ

FDA drug recall D-0011-2025 was initiated by VIONA PHARMACEUTICALS INC on Sep 24, 2024 and is designated Class II. Reason for recall: Crystallization The recall status is ongoing. Affected quantity: 2544 pumps.

Recall details

Product Type
Drugs
Report Date
Oct 23, 2024
Initiation Date
Sep 24, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2544 pumps

Product description

Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.

Reason for recall

Crystallization

Distribution pattern

NY

Code information

Lot #: T400512, Exp 02/28/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0011-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0011-2025. Report a data issue: hello@regdatalab.com.